American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
50.32
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
50.35
+0.03 (0.06%)
After-hours: Apr 28, 2026, 7:03 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 53.09, with a low estimate of 37 and a high estimate of 60. The average target predicts an increase of 5.50% from the current stock price of 50.32.
Analyst Consensus: Buy
* Price targets were last updated on Mar 13, 2026.
Analyst Ratings
The average analyst rating for American Healthcare REIT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $52 → $57 | Strong Buy | Maintains | $52 → $57 | +13.28% | Mar 13, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $55 → $59 | Buy | Maintains | $55 → $59 | +17.25% | Mar 11, 2026 |
| Citigroup | Citigroup | Hold Maintains $52 → $55 | Hold | Maintains | $52 → $55 | +9.30% | Mar 2, 2026 |
| Citizens | Citizens | Buy Reiterates $60 | Buy | Reiterates | $60 | +19.24% | Feb 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $55 | Buy | Initiates | $55 | +9.30% | Jan 29, 2026 |
Financial Forecast
Revenue This Year
287.80M
from 2.26B
Decreased by -87.26%
Revenue Next Year
304.38M
from 287.80M
Increased by 5.76%
EPS This Year
0.12
from 0.42
Decreased by -70.74%
EPS Next Year
0.17
from 0.12
Increased by 41.67%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 312.2M | 317.6M | |
| Avg | 287.8M | 304.4M | |
| Low | 262.5M | 288.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -86.2% | 10.4% | |
| Avg | -87.3% | 5.8% | |
| Low | -88.4% | 0.2% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.13 | 0.18 |
| Avg | 0.12 | 0.17 |
| Low | 0.12 | 0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | -69.9% | 45.8% |
| Avg | -70.7% | 41.7% |
| Low | -71.9% | 36.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.